WORK Medical Technology Group (WOK) Company Report

Analyst Coverage

Research analysts covering WORK Medical Technology Group.

Recent press releases and 8-K filings for WOK.

WORK Medical Technology Group LTD Sells Class B Shares to COO-Owned Entity

WOK

New Projects/Investments

On December 30, 2025, WORK Medical Technology Group LTD entered into a securities purchase agreement with LWY GROUP LTD, an entity wholly owned by its chief operating officer, Baiming Yu.
LWY GROUP LTD agreed to purchase 100,000 Class B ordinary shares from the Company for an aggregate price of $500,000.
As a result of this transaction, Baiming Yu, through LWY GROUP, will beneficially own 100,625 Class B ordinary shares, representing approximately 54.96% of the aggregate voting power of the Company's outstanding ordinary shares.
The closing of this transaction is anticipated to occur on or about January 13, 2026.

Jan 5, 2026, 1:00 PM

WORK Medical Technology Group LTD announces 100:1 share consolidation

WOK

Delisting/Listing Issues

WORK Medical Technology Group LTD implemented a 100:1 consolidation of its ordinary shares, which became effective on December 29, 2025.
The primary reason for this share consolidation was to meet the Nasdaq Stock Market's continued listing standard regarding the minimum bid price (Nasdaq Listing Rule 5550(a)(2)) and to mitigate the risk of the company being delisted from Nasdaq.
Following the consolidation, the company's Class A ordinary shares continue to trade on Nasdaq under the same symbol "WOK".
As a result of the consolidation, the number of issued and outstanding ordinary shares decreased from 122,001,406 as of December 28, 2025, to approximately 1,220,015 as of the effective date.

Dec 30, 2025, 9:15 PM

WOK Enters Sales Agreement for Up to $200 Million Share Offering

WOK

On November 20, 2025, WORK Medical Technology Group LTD entered into a sales agreement with AC Sunshine Securities, LLC to offer and sell Class A ordinary shares.
The company may offer and sell Class A ordinary shares for an aggregate offering price of up to $200,000,000.
AC Sunshine Securities, LLC will act as the sales agent and receive a commission of 3.5% of the aggregate gross proceeds from each sale.
The offering will be conducted as an "at the market offering".
The company is not obligated to sell any shares under the agreement.

Nov 24, 2025, 10:20 PM

WORK Medical Technology Group LTD to Hold Extraordinary General Meeting to Address Nasdaq Delisting Concerns

WOK

Delisting/Listing Issues

Proxy Vote Outcomes

WORK Medical Technology Group LTD (WOK) will hold an Extraordinary General Meeting on November 7, 2025, to vote on proposals primarily aimed at addressing Nasdaq listing compliance issues.
The company received a delisting notification from Nasdaq on October 9, 2025, for non-compliance with the Low Priced Stocks Rule. An appeal was filed on October 16, 2025, staying the delisting pending a hearing on November 11, 2025.
Shareholders will vote to ratify a 100:1 share consolidation that became market effective on October 21, 2025, and to approve one or more additional share consolidations with a ratio between 2:1 and 250:1 to meet Nasdaq's minimum bid price requirements. As of October 21, 2025, following the 100:1 consolidation, there are approximately 1,035,913 Ordinary Shares issued and outstanding.

Oct 21, 2025, 8:10 PM

WORK Medical Technology Group LTD announces pricing of registered direct offering

WOK

WORK Medical Technology Group LTD announced the pricing of a registered direct offering on September 25, 2025, expecting to generate approximately $2.9 million in gross proceeds.
The offering includes the sale of 38,999,334 Class A ordinary shares or pre-funded warrants at a purchase price of $0.075 per share.
The transaction closed on September 26, 2025, with the net proceeds intended for working capital and general corporate purposes.
Univest Securities, LLC acted as the sole placement agent, receiving a fee of 8.0% of the aggregate gross proceeds.

Sep 29, 2025, 8:10 PM

WORK Medical Technology Group LTD Reports Financial Results for Six Months Ended March 31, 2025

WOK

Earnings

Demand Weakening

New Projects/Investments

For the six months ended March 31, 2025, WORK Medical Technology Group LTD reported revenues of $4,543,585, a 14.4% decrease compared to the prior year, and a net loss of $29,425, contrasting with net income of $234,854 for the six months ended March 31, 2024.
Despite the revenue decline, the company's gross margin improved to 34.4% for the six months ended March 31, 2025, up from 29.1% in the prior year, primarily due to an increased sales proportion of higher-margin medical devices.
Cash and cash equivalents significantly decreased to $1,995,767 as of March 31, 2025, from $6,557,605 as of September 30, 2024.
The company is undergoing a strategic adjustment, scaling down its mask business due to market saturation and expanding investment in higher-value medical devices, which constituted 92.4% of sales for the six months ended March 31, 2025.

Aug 25, 2025, 12:00 AM

Get instant answers from SEC filings, earnings calls & more